FDA approves Botox for crow's feet

If you have a high school reunion coming up, here's a medical development that you may want to keep an eye on.

Federal regulators for the first time have approved Botox injections to treat crow's feet.

The Food and Drug Administration said Wednesday that Allergan's Botox Cosmetic injection is the first drug approved to treat the wrinkles that form on the outside edge of the eyes.

Allergan Inc. studied use of the drug in 833 adults with crow's feet who randomly received Botox or a sham injection. Patients who received Botox had fewer visible wrinkles than those who received the placebo drug.

The most common side effects seen in patients were swelling and excess liquid around the eyelids.


Explore further

Botox developer rues missing out on billions

© 2013 The Associated Press. All rights reserved.

Citation: FDA approves Botox for crow's feet (2013, September 11) retrieved 6 December 2019 from https://medicalxpress.com/news/2013-09-fda-botox-crow-feet.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments